课题基金 / 基金详情

CEREBRAL PERFUSION AND COGNITIVE DECLINE IN TYPE 2 DIABETES

CEREBRAL PERFUSION AND COGNITIVE DECLINE IN TYPE 2 DIABETES
2 型糖尿病的脑灌注和认知能力下降
批准号:
7718917
负责人:
VERA NOVAK
金额:
$0.78万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-01 至 2008-05-31

项目摘要

项目成果

VERA NOVAK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this study is to determine the mechanisms by which type 2 diabetes mellitus (DM) affects cerebral perfusion in older adults and by which uncontrolled DM contributes to cognitive impairment. The first hypothesis is that type 2 diabetes mellitus is associated with cerebral microvascular disease, presenting as impairments in vasoregulation and blood flow distribution, white matter abnormalities on MRI, and declined cognitive performance. The second hypothesis is that poor glycemic control increases the severity of microvascular disease in elderly people with type 2 diabetes mellitus. Also, higher hemoglobin A1c levels are associated with reduced cerebral blood flow and more WMC and executive dysfunction. In addition, disturbance of blood flow regulation in the frontotemporal cortex and periventricular white matter changes contribute to executive dysfunction in type 2 DM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID)
Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID)
Enhancing cerebral vasoreativity & cognition by intranasal insulin in T2DM
Enhancement of cerebral vasoreactivity and cognition by intranasal insulin in typ
海外基金